Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

Author： Treanor J.J.   Kotloff K.   Betts R.F.   Belshe R.   Newman F.   Iacuzio D.   Wittes J.   Bryant M.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.18, Iss.9, 1999-12, pp. : 899-906

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant

By Powers D.C.   Hanscome P.J.   Pietrobon P.J.F.  

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1330-1335

Elsevier

Access to resources Recommend Favorite

Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects

By Treanor J.J.   Betts R.F.  

Vaccine, Vol. 16, Iss. 18, 1998-11 ,pp. : 1756-1760

Elsevier

Access to resources Recommend Favorite

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

By Gorse G.J.   O'Connor T.Z.   Young S.L.   Mendelman P.M.   Bradley S.F.   Nichol K.L.   Strickland J.H.   Paulson D.M.   Rice K.L.   Foster R.A.   Fulambarker A.M.   Shigeoka J.W.   Kuschner W.G.   Goodman R.P.   Neuzil K.M.   Wittes J.   Boardman K.D.   Peduzzi P.N.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2142-2153

Elsevier

Access to resources Recommend Favorite

Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses

By Romanova J.R.   Tannock G.A.   Alexandrova G.I.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 653-658

Elsevier

Access to resources Recommend Favorite

A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses

By Rimmelzwaan G.F.   Baars M.   van Amerongen G.   van Beek R.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 158-163

Elsevier

Access to resources Recommend Favorite